ADELINO FRANCO ANA RITA

(2024). Development of New Toll-Like Receptor 4-directed adjuvants and Clarification of
their Mechanism of Action. (Tesi di dottorato, Università degli Studi di Milano-Bicocca, 2024). Dettaglio

Romerio, A., Franco, A., Shadrick, M., Shaik, M., Artusa, V., Italia, A., et al. (2023). Overcoming Challenges in Chemical Glycosylation to Achieve Innovative Vaccine Adjuvants Possessing Enhanced TLR4 Activity. ACS OMEGA, 8(39), 36412-36417 [10.1021/acsomega.3c05363]. Dettaglio

Romerio, A., Gotri, N., Franco, A., Artusa, V., Shaik, M., Pasco, S., et al. (2023). New Glucosamine-Based TLR4 Agonists: Design, Synthesis, Mechanism of Action, and In Vivo Activity as Vaccine Adjuvants. JOURNAL OF MEDICINAL CHEMISTRY, 66(4), 3010-3029 [10.1021/acs.jmedchem.2c01998]. Dettaglio

Ami, D., Franco, A., Artusa, V., Mereghetti, P., Peri, F., Natalello, A. (2022). A Global Picture of Molecular Changes Associated to LPS Treatment in THP-1 Derived Human Macrophages by Fourier Transform Infrared Microspectroscopy. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 23(21) [10.3390/ijms232113447]. Dettaglio

Franco, A., Peri, F. (2021). Developing New Anti-Tuberculosis Vaccines: Focus on Adjuvants. CELLS, 10(1), 1-17 [10.3390/cells10010078]. Dettaglio